Lorazepam Injection Shortage: Current Availability and Manufacturer Updates

Drug Shortages high FDA · · United States

The FDA has reported a current shortage of Lorazepam Injection due to increased demand, with supply issues expected to continue through early 2026.

What’s in Shortage

There is currently a shortage of Lorazepam Injection, a medication within the Neurology therapeutic category. This shortage affects the generic form of the drug as well as products labeled under the brand name LORAZEPAM. The specific dosage form impacted is the injection.

As of the latest update on February 5, 2026, the shortage remains listed as “Current” by the FDA.

Which Manufacturers Are Affected

The following manufacturer has reported availability issues:

  • Fresenius Kabi USA, LLC
    • Status: Unavailable
    • Presentation: Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)
    • Notes: The manufacturer estimates the next release of this product will be in March 2026.
    • Contact Information: 888-386-1300

Why There’s a Shortage

According to the FDA database, the reason for this shortage is a demand increase for the drug. This shortage was first posted on May 3, 2018, and has been subject to ongoing monitoring.

What Patients Should Do

If you or a loved one are prescribed Lorazepam Injection, please consider the following steps:

  • Consult Your Healthcare Provider: Speak with your doctor or specialist about how this shortage may affect your treatment plan.
  • Speak with a Pharmacist: Your pharmacist can provide the most current information on local availability and stock levels.
  • Contact the Manufacturer: You may reach out to Fresenius Kabi USA, LLC at 888-386-1300 for specific inquiries regarding their supply timeline.
  • Inquire About Alternatives: Ask your healthcare provider if there are suitable alternative medications or different dosage forms available during this period.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medication changes or treatment options.

Source

This information is based on data from the FDA Drug Shortage Database. Initial Posting Date: 05/03/2018
Last Updated: 02/05/2026